Common Contracts
5 similar Change of Control Agreement contracts by Poniard Pharmaceuticals, Inc., Fisher Communications Inc
PONIARD PHARMACEUTICALS, INC. CHANGE OF CONTROL AGREEMENTChange of Control Agreement • February 11th, 2010 • Poniard Pharmaceuticals, Inc. • Pharmaceutical preparations
This Change of Control Agreement (this “Agreement”), dated as of February 5, 2010, is entered into by and between PONIARD PHARMACEUTICALS, INC., a Washington corporation (as supplemented by Section 13 hereof, the “Company”), and Michael S. Perry, DVM, Ph.D. (the “Executive”).
FISHER COMMUNICATIONS, INC. FORM OF CHANGE OF CONTROL AGREEMENTChange of Control Agreement • August 28th, 2009 • Fisher Communications Inc • Television broadcasting stations
This Change of Control Agreement (this "Agreement”), is entered into by and between Fisher Communications, Inc., a Washington corporation (as supplemented by Section 13 hereof, the “Company”), and (the “Executive”) as of , 2009.
FISHER COMMUNICATIONS, INC. CHANGE OF CONTROL AGREEMENT (As Amended and Restated on August 24, 2009Change of Control Agreement • August 28th, 2009 • Fisher Communications Inc • Television broadcasting stations
This Change of Control Agreement, as amended and restated (this "Agreement”), is entered into by and between Fisher Communications, Inc., a Washington corporation (as supplemented by Section 13 hereof, the “Company”), and Colleen B. Brown (the “Executive”) as of August 24, 2009.
PONIARD PHARMACEUTICALS, INC. CHANGE OF CONTROL AGREEMENTChange of Control Agreement • March 16th, 2009 • Poniard Pharmaceuticals, Inc. • Pharmaceutical preparations • California
This Change of Control Agreement (this “Agreement”), dated as of February 18, 2009, is entered into by and between PONIARD PHARMACEUTICALS, INC., a Washington corporation (as supplemented by Section 13 hereof, the “Company”), and Greg Weaver (the “Executive”).
PONIARD PHARMACEUTICALS, INC. AMENDED AND RESTATED CHANGE OF CONTROL AGREEMENT (CEO)Change of Control Agreement • March 16th, 2009 • Poniard Pharmaceuticals, Inc. • Pharmaceutical preparations
This Amended and Restated Change of Control Agreement (CEO) (this “Agreement”), dated as of February 24, 2009, is entered into by and between PONIARD PHARMACEUTICALS, INC., a Washington corporation (formerly known as NeoRx Corporation and as supplemented by Section 13 hereof, the “Company”), and GERALD MCMAHON (the “Executive”) to reflect amendments made in December, 2008.
